Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,625
Closed -$213K 498
2025
Q1
$213K Sell
4,625
-950
-17% -$39.7K 0.02% 443
2024
Q4
$210K Buy
5,575
+508
+10% +$19.7K 0.02% 471
2024
Q3
$205K Buy
+5,067
New +$191K 0.02% 440
2019
Q3
Sell
-139
Closed -$3K 393
2019
Q2
$3K Hold
139
﹤0.01% 632
2019
Q1
$3K Hold
139
﹤0.01% 611
2018
Q4
$3K Hold
139
﹤0.01% 588
2018
Q3
$3K Buy
139
+30
+28% +$923 ﹤0.01% 595
2018
Q2
$2K Buy
109
+47
+76% +$1.35K ﹤0.01% 675
2018
Q1
$1K Buy
62
+17
+38% +$459 ﹤0.01% 712
2017
Q4
$1K Buy
+45
New +$1.29K ﹤0.01% 690

Other funds holding EXC

Avestar Capital's EXC Position: Q2 2025 in Review

Avestar Capital sold out of Exelon (EXC) in Q2 2025, closing a stake of 4,625 shares — an estimated $213K sold.

Avestar Capital first reported a position in EXC in Q4 2017 and held it in 10 quarters. The position peaked at $213K in Q1 2025. 1,176 funds tracked by Wall St. Rank hold EXC as of Q2 2025.

  • Avestar Capital reported no remaining Exelon position as of Q2 2025 after selling out during the quarter.
  • Avestar Capital sold 4,625 Exelon shares in Q2 2025, an estimated $213K.
  • Avestar Capital first reported a position in Exelon in Q4 2017 and held it in 10 quarters.
  • Avestar Capital's Exelon position peaked at $213K in Q1 2025.
  • 1,176 funds tracked by Wall St. Rank held Exelon as of Q2 2025.

Based on Avestar Capital's 13F filing for Q2 2025, filed 13 Aug 2025.